CoChat

The role of automated insulin delivery technology in diabetes

Open access
Boughton, Charlotte K., Hovorka, Roman · 2024 · Diabetologia

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop systems are being used in routine clinical practice for treating people with type 1 diabetes. Encouragingly, real-world data reflects the performance and usability observed in clinical trials. We review the commercially available hybrid closed-loop systems, their distinctive features and the associated real-world data. We also consider emerging indications for closed-loop systems, including the treatment of type 2 diabetes where variability of day-to-day insulin requirements is high, and other challenging applications for this technology. We discuss issues around access and implementation of closed-loop technology, and consider the limitations of present closed-loop systems, as well as innovative approaches that are being evaluated to improve their performance. Graphical Abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-024-06165-w

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The closed-loop ecosystem. Before starting to use a closed-loop system users require training and support on the devices. Once users are on board, data from the closed-loop system is uploaded to a data management platform and can be visualised in real-time by caregivers/family members (follower function) and by healthcare providers to support optimisation of diabetes management. In the event of device issues, users will need to contact customer support for assistance. This figure is available as part of a downloadable slideset
Fig. 1 The closed-loop ecosystem. Before starting to use a closed-loop system users require training and support on the devices. Once users are on board, data from the closed-loop system is uploaded to a data management platform and can be visualised in real-time by caregivers/family members (follower function) and by healthcare providers to support optimisation of diabetes management. In the event of device issues, users will need to contact customer support for assistance. This figure is available as part of a downloadable slidesetCC BY · PubMed Central
Fig. 2 Variability of day-to-day insulin requirements as determined by closed-loop insulin delivery across different populations with diabetes. Data presented are mean with SD. Samples size: type 1 diabetes age 1–6 years n=20, 7–12 years n=21, 13–17 years n=18, adults n=58; type 2 diabetes outpatients n=25, inpatients n=67 (data from references [43, 44, 65]). IP, inpatients; OP, outpatients; T1D, type 1 diabetes, T2D, type 2 diabetes; y, years. This figure is available as part of a downloadable slideset
Fig. 2 Variability of day-to-day insulin requirements as determined by closed-loop insulin delivery across different populations with diabetes. Data presented are mean with SD. Samples size: type 1 diabetes age 1–6 years n=20, 7–12 years n=21, 13–17 years n=18, adults n=58; type 2 diabetes outpatients n=25, inpatients n=67 (data from references [43, 44, 65]). IP, inpatients; OP, outpatients; T1D, type 1 diabetes, T2D, type 2 diabetes; y, years. This figure is available as part of a downloadable slidesetCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. International Diabetes Federation (2019) IDF Diabetes Atlas 9th Edition 2019. Available from https://diabetesatlas.org/idfawp/resource-files/2019/07/IDF_diabetes_atlas_ninth_edition_en.pdf

Cited by

See all 57

Metadata

Authors
Boughton, C. K., & Hovorka, R.
Affiliations
University of Cambridge (GB)
Corresponding author
Boughton, Charlotte K.
Venue
Diabetologia
Published
2024-05-13
Volume
67
Issue
10
Pages
2034-2044
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W4396850881
Cited by
57
References
62
Citations by year
2026: 26 · 2025: 25 · 2024: 6
FWCI
3.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Institute for Health and Care Research (14/23/09)
  • Department of Health and Social Care
  • NIHR Cambridge Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
artificial pancreas, hybrid closed-loop system, type 1 diabetes, type 2 diabetes, insulin pump therapy, real-world data
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of automated insulin delivery technology in diabetes. https://app.cochat.ai/papers/10.1007/s00125-024-06165-w
The paper
Boughton, C. K., & Hovorka, R. (2024). The role of automated insulin delivery technology in diabetes. Diabetologia. https://doi.org/10.1007/s00125-024-06165-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.